CORCEPT THERAPEUTICS INC — Director's Dealing 2017

May 8, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2017-05-04

Reporting Person: Robb Gary Charles (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-04	Common Stock	P	5600	$9.7479	Acquired	6858	Direct

Footnotes

F1: Represents the weighted average purchase price for the entire number of shares purchased. The actual purchase prices range from $9.7470 to $9.7499 per share. Detailed information on the exact number of shares purchased at each purchase price can be obtained from the issuer upon request.